Vasomera
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vasomera, covering 2013-01-04 to 2014-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension [Phase 1]